Endocrinology, Vol 127, 1078-1086, Copyright © 1990 by Endocrine Society

ARTICLES

Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart

RS Bar, DR Clemmons, M Boes, WH Busby, BA Booth, BL Dake and A Sandra
Department of Internal Medicine, Veterans Administration Hospital, University of Iowa, Iowa City 52246.

Insulin-like growth factor (IGF) binding proteins (IGFBP) were purified from conditioned media of cultured bovine endothelial cells (ECBP) and from human amniotic fluid (IGFBP-1), and then labeled by radioiodination. 125I-ECBP and 125I-IGFBP-1 were perfused through isolated beating rat hearts for 1 and 5 min, and the hearts fixed and analyzed for 125I-BP content and distribution. One to 4% of the perfused 125I-ECBP and 125I-IGFBP-1 crossed the capillary boundary. The ECBPs predominantly localized as intact 125I-BP in connective tissue elements of the heart with less 125I-BP in cardiac muscle. The ratio of 125I-ECBP in connective tissue: muscle (normalized to percent vol of these compartments) was greater than or equal to 10:1. In contrast, the IGFBP-1 had a greater affinity for cardiac muscle with ratios of 125I- IGFBP-1 in connective tissue:muscle of approximately 1:2. When 125I-IGF- I, in the absence of any BPs, was perfused through the hearts approximately 3-5% left the microcirculation and was found in subendothelial tissues. 125I-IGF-I localized primarily to cardiac muscle with a distribution of connective tissue:cardiac muscle of about 1:3. The findings in the isolated perfused heart were confirmed in intact animals. After 125I-IGFBP-1 was injected into anesthetized rats and allowed to circulate for 5 min, substantial radioactivity was associated with the heart. As in the isolated heart, the IGFBP-1 preferentially localized to cardiac muscle with a connective tissue:cardiac muscle ratio of 1:3. We conclude that IGFBPs produced by endothelial cells and the IGFBP-1 contained in amniotic fluid can cross the capillary boundaries of the rat heart, and that the ECBPs preferentially localize in connective tissue elements of the myocardium, whereas IGFBP-1 predominantly localizes in cardiac muscle.

This article has been cited by other articles:

				S Llewellyn, R Fitzpatrick, D A Kenny, J J Murphy, R J Scaramuzzi, and D C Wathes Effect of negative energy balance on the insulin-like growth factor system in pre-recruitment ovarian follicles of post partum dairy cows Reproduction, March 1, 2007; 133(3): 627 - 639. [Abstract] [Full Text] [PDF]

				M. Haluzik, S. Yakar, O. Gavrilova, J. Setser, Y. Boisclair, and D. LeRoith Insulin Resistance in the Liver-Specific IGF-1 Gene-Deleted Mouse Is Abrogated by Deletion of the Acid-Labile Subunit of the IGF-Binding Protein-3 Complex: Relative Roles of Growth Hormone and IGF-1 in Insulin Resistance Diabetes, October 1, 2003; 52(10): 2483 - 2489. [Abstract] [Full Text] [PDF]

				J L Chicharro, A Lopez-Calderon, J Hoyos, A I Martin-Velasco, G Villa, M A Villanua, and A Lucia Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3 Br. J. Sports Med., October 1, 2001; 35(5): 303 - 307. [Abstract] [Full Text] [PDF]

				K. L. Knudtson, M. Boes, A. Sandra, B. L. Dake, B. A. Booth, and R. S. Bar Distribution of Chimeric IGF Binding Protein (IGFBP)-3 and IGFBP-4 in the Rat Heart: Importance of C-Terminal Basic Region Endocrinology, September 1, 2001; 142(9): 3749 - 3755. [Abstract] [Full Text] [PDF]

				P. J. D. Delhanty, C. D. Scott, S. Babu, and R. C. Baxter Acid-labile subunit regulation during the early stages of liver regeneration: implications for glucoregulation Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E287 - E295. [Abstract] [Full Text] [PDF]

				J. A. M. J. L. Janssen, R. P. Stolk, H. A. P. Pols, D. E. Grobbee, and S. W. J. Lamberts Serum Total IGF-I, Free IGF-I, and IGFBP-1 Levels in an Elderly Population : Relation to Cardiovascular Risk Factors and Disease Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 277 - 282. [Abstract] [Full Text] [PDF]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				S. Manes, L. Kremer, J. P. Albar, C. Mark, R. Llopis, and C. Martinez-A Functional Epitope Mapping of Insulin-Like Growth Factor I (IGF-I) by Anti-IGF-I Monoclonal Antibodies Endocrinology, March 1, 1997; 138(3): 905 - 915. [Abstract] [Full Text] [PDF]

				M. Westwood, J M. Gibson, and A. White Purification and Characterization of the Insulin-Like Growth Factor-Binding Protein-1 Phosphoform Found in Normal Plasma Endocrinology, March 1, 1997; 138(3): 1130 - 1136. [Abstract] [Full Text] [PDF]